Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1979 Dec;76(12):6401–6405. doi: 10.1073/pnas.76.12.6401

Quantitative relationship between β-adrenergic receptor number and physiologic responses as studied with a long-lasting β-adrenergic antagonist

Wesley L Terasaki 1, Joel Linden 1, Gary Brooker 1,*
PMCID: PMC411872  PMID: 42915

Abstract

The aminobenzyl analog of propranolol, 1- (p-amino-α,α-dimethylphenethylamino)-3-(1-naphthoxy)-2- propanol, was synthesized and found to be a potent β-adrenergic blocking agent. The β-adrenergic receptors of cultured rat C6 glioma cells (2B clone) as assessed by [125I]iodohydroxybenzylpindolol binding were decreased 50 and >95% after pretreatment with 8 nM and 1 μM aminobenzylpropranolol, respectively. Unlike propranolol, aminobenzylpropranolol displayed a prolonged blockade of receptors that was maintained during several hours of washing. [125I]Iodohydroxybenzylpindolol saturation binding experiments in cells exposed to aminobenzylpropranolol and subsequently washed indicated that the compound effectively diminished receptor number with no change in the affinity of the remaining receptors for iodohydroxybenzylpindolol. Aminobenzylpropranolol inhibited catecholamine-stimulated intracellular cyclic AMP accumulation; with increasing blockade, isoproterenol dose—response curves became progressively shifted to the right but the maximal response was unaltered. Aminobenzylpropranolol inhibited the β-adrenergic contractile response in atria isolated from rats and guinea pigs. Treatment with 0.1 and 10 μM aminobenzylpropranolol produced decreases of 0.5 and 2 orders of magnitude in the contractile potency of isoproterenol. As in glioma cells, aminobenzylpropranolol failed to decrease the maximal response to isoproterenol. The effects of aminobenzylpropranolol persisted during extensive washing of atria (up to 17 hr). Repeated exposures to isoproterenol at concentrations sufficient to produce maximal tension development also failed to alleviate the blockade. The inotropic potency of histamine in guinea pig atria was not affected by aminobenzylpropranolol. These data suggest that catecholamines are capable of eliciting full biological responses in glioma cells and isolated atria even though the great majority of β-adrenergic receptors are persistently blocked.

Keywords: receptors, cyclic AMP, aminobenzylpropranolol, iodohydroxybenzylpindolol, isoproterenol

Full text

PDF
6401

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atlas D., Steer M. L., Levitzki A. Affinity label for beta-adrenergic receptor in turkey erythrocytes. Proc Natl Acad Sci U S A. 1976 Jun;73(6):1921–1925. doi: 10.1073/pnas.73.6.1921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bayley H., Knowles J. R. Photoaffinity labeling. Methods Enzymol. 1977;46:69–114. doi: 10.1016/s0076-6879(77)46012-9. [DOI] [PubMed] [Google Scholar]
  3. Crowther A. F., Smith L. H. Beta-adrenergic blocking agents. II. Propranolol and related 3-amino-1-naphthoxy-2-propanols. J Med Chem. 1968 Sep;11(5):1009–1013. doi: 10.1021/jm00311a021. [DOI] [PubMed] [Google Scholar]
  4. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  5. Howe R., Crowther A. F., Stephenson J. S., Rao B. S., Smith L. H. Beta-adrenergic blocking agents. I. Pronethalol and related N-alkyl and N-aralkyl derivatives of 2-amino-1-(2-naphythyl)ethanol. J Med Chem. 1968 Sep;11(5):1000–1008. doi: 10.1021/jm00311a020. [DOI] [PubMed] [Google Scholar]
  6. Insel P. A., Stoolman L. M. Radioligand binding to beta adrenergic receptors of intact cultured S49 cells. Mol Pharmacol. 1978 Jul;14(4):549–561. [PubMed] [Google Scholar]
  7. Lefkowitz R. J., Williams L. T. Molecular mechanisms of activation and desensitization of adenylate cyclase coupled beta-adrenergic receptors. Adv Cyclic Nucleotide Res. 1978;9:1–17. [PubMed] [Google Scholar]
  8. Levitzki A. The mode of coupling of adenylate cyclase to hormone receptors and its modulation by GTP. Biochem Pharmacol. 1978;27(17):2083–2088. doi: 10.1016/0006-2952(78)90276-9. [DOI] [PubMed] [Google Scholar]
  9. Maguire M. E., Wiklund R. A., Anderson H. J., Gilman A. G. Binding of (125I)iodohydroxybenzylpindolol to putative beta-adrenergic receptors of rat glioma cells and other cell clones. J Biol Chem. 1976 Mar 10;251(5):1221–1231. [PubMed] [Google Scholar]
  10. Sporn J. R., Wolfe B. B., Harden T. K., Molinoff P. B. Supersensitivity in rat cerebral cortex: pre- and postsynaptic effects of 6-hydroxydopamine at noradrenergic synapses. Mol Pharmacol. 1977 Nov;13(6):1170–1180. [PubMed] [Google Scholar]
  11. Su Y. F., Harden T. K., Perkins J. P. Isoproterenol-induced desensitization of adenylate cyclase in human astrocytoma cells. Relation of loss of hormonal responsiveness and decrement in beta-adrenergic receptors. J Biol Chem. 1979 Jan 10;254(1):38–41. [PubMed] [Google Scholar]
  12. Takayanagi I., Yoshioka M., Takagu K., Tamura Z. Photoaffinity labeling of the beta-adrenergic receptors and receptor reserve for isoprenaline. Eur J Pharmacol. 1976 Jan;35(1):121–125. doi: 10.1016/0014-2999(76)90306-x. [DOI] [PubMed] [Google Scholar]
  13. Terasaki W. L., Brooker G. [125I]Iodohydroxybenzylpindolol binding sites on intact rat glioma cells. Evidence for beta-adrenergic receptors of high coupling efficiency. J Biol Chem. 1978 Aug 10;253(15):5418–5425. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES